Alibaba Health Information Technology Ltd (ALBBY)
8.62
0.00 (0.00%)
USD |
OTCM |
Jun 26, 16:00
Alibaba Health Information Technology Debt to Equity Ratio: 0.00 for Sept. 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| September 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| September 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| September 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| September 30, 2019 | 0.1992 |
| March 31, 2019 | 0.6083 |
| September 30, 2018 | 0.4663 |
| March 31, 2018 | 0.00 |
| September 30, 2017 | 0.1782 |
| March 31, 2017 | 0.1698 |
| Date | Value |
|---|---|
| September 30, 2016 | 0.0833 |
| March 31, 2016 | 0.00 |
| September 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| September 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| September 30, 2013 | 0.0827 |
| March 31, 2013 | 0.00 |
| September 30, 2012 | 0.0311 |
| March 31, 2012 | 0.00 |
| September 30, 2011 | 0.0317 |
| March 31, 2011 | 0.058 |
| September 30, 2010 | 0.3677 |
| March 31, 2010 | 0.0263 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2020
0.1992
Maximum
Sep 2019
0.0221
Average
--
Median
Mar 2020
Debt to Equity Ratio Benchmarks
| Sinovac Biotech Ltd | 0.0292 |
| CASI Pharmaceuticals Inc | 1.202 |
| Zai Lab Ltd | 0.0633 |
| Adagene Inc | 0.3109 |
| LakeShore Biopharma Co Ltd | 0.9778 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.938B |
| Total Liabilities (Quarterly) | 737.09M |
| Shareholders Equity (Quarterly) | 2.205B |
| Current Ratio | 3.01 |